Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1299
Title: Accelerated repetitive transcranial magnetic stimulation in the treatment of depression.
Epworth Authors: Fitzgerald, Paul
Other Authors: Hoy, Kate
Elliot, David
McQueen, Susan
Wambeek, Lenore
Daskalakis, Zafiris
Keywords: Repetitive Transcranial Magnetic Stimulation
rTMS
Major Depressive Disorder
MDD
Treatment Response
Accelerated rTMS
Standard rTMS
Remission Rates
Response Rates
Depression
Rehabilitation, Mental Health and Chronic Pain Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Feb-2018
Publisher: Nature Publishing Group
Citation: Neuropsychopharmacology. 2018 Feb 5
Abstract: Repetitive transcranial magnetic stimulation (rTMS) is increasingly used clinically in the treatment of patients with major depressive disorder (MDD). However, rTMS treatment response can be slow. Early research suggests that accelerated forms of rTMS may be effective but no research has directly evaluated a schedule of accelerated rTMS compared to standard rTMS. To assess the efficacy of accelerated rTMS compared to standard daily rTMS., 115 outpatients with MDD received either accelerated rTMS (n = 58) (i.e., 63,000 high frequency rTMS pulses delivered as 3 treatments per day over 3 days in week 1, 3 treatments over 2 days in week 2 and 3 treatments on a single day in week 3) or standard rTMS (n = 57) (i.e., 63,000 total high frequency rTMS pulses delivered over 5 days per week for 4 weeks) following randomization. There were no significant differences in remission or response rates (p > 0.05 for all analyses) or reduction in depression scores (Time by group interaction (F (5, 489.452) = 1.711, p = 0.130) between the accelerated and standard rTMS treatment groups. Accelerated treatment was associated with a higher rate of reported treatment discomfort. It is feasible to provide accelerated rTMS treatment for outpatients with depression and this is likely to produce meaningful antidepressant effects.
URI: http://hdl.handle.net/11434/1299
DOI: 10.1038/s41386-018-0009-9
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/29467437
ISSN: 0893-133X
1740-634X
Journal Title: Neuropsychopharmacology
Type: Journal Article
Affiliated Organisations: Monash Alfred Psychiatry Research Centre, The Alfred and Monash University Central Clinical School, Victoria, Australia.
Department of Psychiatry, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada.
Type of Clinical Study or Trial: Comparative Study
Appears in Collections:Mental Health

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.